Search tips
Search criteria 


Logo of jcinvestThe Journal of Clinical InvestigationCurrent IssueArchiveSubscriptionAbout the Journal
J Clin Invest. 1996 January 1; 97(1): 258–262.
PMCID: PMC507088

Human diabetes associated with defects in nuclear regulatory proteins for the insulin receptor gene.


The control of gene transcription is mediated by sequence-specific DNA-binding proteins (trans-acting factors) that bind to upstream regulatory elements (cis elements). We have previously identified two DNA-binding proteins that specifically interact with two unique AT-rich sequences of the 5' regulatory region of the insulin receptor gene which have in vivo promoter activity. Herein we have investigated the expression of these DNA-binding proteins in cells from two unrelated patients with insulin resistance and non-insulin-dependent diabetes mellitus. In these patients, the insulin receptor gene was normal. In EBV-transformed lymphoblasts from both patients, insulin receptor mRNA levels and insulin receptor expression were decreased. The expression of nuclear-binding proteins for the 5' regulatory region of the insulin receptor gene was markedly reduced, and this defect paralleled the decrease in insulin receptor protein expression. These studies indicate that DNA-binding proteins to the regulatory region of the insulin receptor gene are important for expression of the insulin receptor. Further, they suggest that in affected individuals, defects in the expression of these proteins may cause decreased insulin receptor expression and insulin resistance.

Full Text

The Full Text of this article is available as a PDF (186K).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Reaven GM. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes. 1988 Dec;37(12):1595–1607. [PubMed]
  • Olefsky JM. LIlly lecture 1980. Insulin resistance and insulin action. An in vitro and in vivo perspective. Diabetes. 1981 Feb;30(2):148–162. [PubMed]
  • Eriksson J, Franssila-Kallunki A, Ekstrand A, Saloranta C, Widén E, Schalin C, Groop L. Early metabolic defects in persons at increased risk for non-insulin-dependent diabetes mellitus. N Engl J Med. 1989 Aug 10;321(6):337–343. [PubMed]
  • Warram JH, Martin BC, Krolewski AS, Soeldner JS, Kahn CR. Slow glucose removal rate and hyperinsulinemia precede the development of type II diabetes in the offspring of diabetic parents. Ann Intern Med. 1990 Dec 15;113(12):909–915. [PubMed]
  • Zimmet PZ. Kelly West Lecture 1991. Challenges in diabetes epidemiology--from West to the rest. Diabetes Care. 1992 Feb;15(2):232–252. [PubMed]
  • Bogardus C. Insulin resistance in the pathogenesis of NIDDM in Pima Indians. Diabetes Care. 1993 Jan;16(1):228–231. [PubMed]
  • Goldfine ID. The insulin receptor: molecular biology and transmembrane signaling. Endocr Rev. 1987 Aug;8(3):235–255. [PubMed]
  • Czech MP. The nature and regulation of the insulin receptor: structure and function. Annu Rev Physiol. 1985;47:357–381. [PubMed]
  • White MF, Shoelson SE, Keutmann H, Kahn CR. A cascade of tyrosine autophosphorylation in the beta-subunit activates the phosphotransferase of the insulin receptor. J Biol Chem. 1988 Feb 25;263(6):2969–2980. [PubMed]
  • Taylor SI. Lilly Lecture: molecular mechanisms of insulin resistance. Lessons from patients with mutations in the insulin-receptor gene. Diabetes. 1992 Nov;41(11):1473–1490. [PubMed]
  • Kahn CR, Flier JS, Bar RS, Archer JA, Gorden P, Martin MM, Roth J. The syndromes of insulin resistance and acanthosis nigricans. Insulin-receptor disorders in man. N Engl J Med. 1976 Apr 1;294(14):739–745. [PubMed]
  • Moller DE, Flier JS. Detection of an alteration in the insulin-receptor gene in a patient with insulin resistance, acanthosis nigricans, and the polycystic ovary syndrome (type A insulin resistance). N Engl J Med. 1988 Dec 8;319(23):1526–1529. [PubMed]
  • Imano E, Kadowaki H, Kadowaki T, Iwama N, Watarai T, Kawamori R, Kamada T, Taylor SI. Two patients with insulin resistance due to decreased levels of insulin-receptor mRNA. Diabetes. 1991 May;40(5):548–557. [PubMed]
  • Taylor SI, Cama A, Accili D, Barbetti F, Quon MJ, de la Luz Sierra M, Suzuki Y, Koller E, Levy-Toledano R, Wertheimer E, et al. Mutations in the insulin receptor gene. Endocr Rev. 1992 Aug;13(3):566–595. [PubMed]
  • Ojamaa K, Hedo JA, Roberts CT, Jr, Moncada VY, Gorden P, Ullrich A, Taylor SI. Defects in human insulin receptor gene expression. Mol Endocrinol. 1988 Mar;2(3):242–247. [PubMed]
  • Yamamoto KR. Steroid receptor regulated transcription of specific genes and gene networks. Annu Rev Genet. 1985;19:209–252. [PubMed]
  • Schleif R. DNA binding by proteins. Science. 1988 Sep 2;241(4870):1182–1187. [PubMed]
  • Mitchell PJ, Tjian R. Transcriptional regulation in mammalian cells by sequence-specific DNA binding proteins. Science. 1989 Jul 28;245(4916):371–378. [PubMed]
  • Seino S, Seino M, Nishi S, Bell GI. Structure of the human insulin receptor gene and characterization of its promoter. Proc Natl Acad Sci U S A. 1989 Jan;86(1):114–118. [PubMed]
  • Sibley E, Kastelic T, Kelly TJ, Lane MD. Characterization of the mouse insulin receptor gene promoter. Proc Natl Acad Sci U S A. 1989 Dec;86(24):9732–9736. [PubMed]
  • Levy JR, Hug V. Nuclear protein-binding analysis of a GC-rich insulin-receptor promoter regulatory region. Diabetes. 1993 Jan;42(1):66–73. [PubMed]
  • Mamula PW, Wong KY, Maddux BA, McDonald AR, Goldfine ID. Sequence and analysis of promoter region of human insulin-receptor gene. Diabetes. 1988 Sep;37(9):1241–1246. [PubMed]
  • Araki E, Shimada F, Uzawa H, Mori M, Ebina Y. Characterization of the promoter region of the human insulin receptor gene. Evidence for promoter activity. J Biol Chem. 1987 Nov 25;262(33):16186–16191. [PubMed]
  • Tewari DS, Cook DM, Taub R. Characterization of the promoter region and 3' end of the human insulin receptor gene. J Biol Chem. 1989 Sep 25;264(27):16238–16245. [PubMed]
  • Seino S, Seino M, Bell GI. Human insulin-receptor gene. Partial sequence and amplification of exons by polymerase chain reaction. Diabetes. 1990 Jan;39(1):123–128. [PubMed]
  • Lee JK, Tam JW, Tsai MJ, Tsai SY. Identification of cis- and trans-acting factors regulating the expression of the human insulin receptor gene. J Biol Chem. 1992 Mar 5;267(7):4638–4645. [PubMed]
  • McKeon C, Moncada V, Pham T, Salvatore P, Kadowaki T, Accili D, Taylor SI. Structural and functional analysis of the insulin receptor promoter. Mol Endocrinol. 1990 Apr;4(4):647–656. [PubMed]
  • Webster NJ, Kong Y, Cameron KE, Resnik JL. An upstream element from the human insulin receptor gene promoter contains binding sites for C/EBP beta and NF-1. Diabetes. 1994 Feb;43(2):305–312. [PubMed]
  • Brunetti A, Foti D, Goldfine ID. Identification of unique nuclear regulatory proteins for the insulin receptor gene, which appear during myocyte and adipocyte differentiation. J Clin Invest. 1993 Sep;92(3):1288–1295. [PMC free article] [PubMed]
  • Goodman PA, Sbraccia P, Brunetti A, Wong KY, Carter JD, Rosenthal SM, Goldfine ID. Growth factor receptor regulation in the Minn-1 leprechaun: defects in both insulin receptor and epidermal growth factor receptor gene expression. Metabolism. 1992 May;41(5):504–509. [PubMed]
  • Taylor SI, Roth J, Blizzard RM, Elders MJ. Qualitative abnormalities in insulin binding in a patient with extreme insulin resistance: decreased sensitivity to alterations in temperature and pH. Proc Natl Acad Sci U S A. 1981 Nov;78(11):7157–7161. [PubMed]
  • Brunetti A, Maddux BA, Wong KY, Goldfine ID. Muscle cell differentiation is associated with increased insulin receptor biosynthesis and messenger RNA levels. J Clin Invest. 1989 Jan;83(1):192–198. [PMC free article] [PubMed]
  • Dignam JD, Lebovitz RM, Roeder RG. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 1983 Mar 11;11(5):1475–1489. [PMC free article] [PubMed]
  • Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976 May 7;72:248–254. [PubMed]
  • O'Neill EA, Fletcher C, Burrow CR, Heintz N, Roeder RG, Kelly TJ. Transcription factor OTF-1 is functionally identical to the DNA replication factor NF-III. Science. 1988 Sep 2;241(4870):1210–1213. [PubMed]
  • Lenardo MJ, Baltimore D. NF-kappa B: a pleiotropic mediator of inducible and tissue-specific gene control. Cell. 1989 Jul 28;58(2):227–229. [PubMed]
  • Tatsumi K, Miyai K, Notomi T, Kaibe K, Amino N, Mizuno Y, Kohno H. Cretinism with combined hormone deficiency caused by a mutation in the PIT1 gene. Nat Genet. 1992 Apr;1(1):56–58. [PubMed]
  • Li S, Crenshaw EB, 3rd, Rawson EJ, Simmons DM, Swanson LW, Rosenfeld MG. Dwarf locus mutants lacking three pituitary cell types result from mutations in the POU-domain gene pit-1. Nature. 1990 Oct 11;347(6293):528–533. [PubMed]

Articles from The Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation